Ji Young Jeon1, Sheen-Woo Lee2, Yu Mi Jeong2, Han Joo Baek3. 1. Department of Radiology, Gil Medical Center, Gachon University College of Medicine, 21 Namdong-daero, 774beon-gil, Namdong-gu, Incheon, 21565, Republic of Korea. mdjeonjy@gmail.com. 2. Department of Radiology, Gil Medical Center, Gachon University College of Medicine, 21 Namdong-daero, 774beon-gil, Namdong-gu, Incheon, 21565, Republic of Korea. 3. Division of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, 21 Namdong-daero, 774beon-gil, Namdong-gu, Incheon, 21565, Republic of Korea.
Abstract
OBJECTIVES: In dual-source CT, dual-energy (DE) performance is affected by various X-ray tube voltage combinations with and without tin filter (Sn). The purpose of this study was to assess the utility of the 80/150 Sn kV voltage combination in terms of image artefact and radiation dose for DECT gout protocol, compared with the conventional 80/140 kV. METHODS: Seventy-four patients with suspected gout who underwent dual-source DECT examinations scanned at 80/140 kV (n = 37) and at 80/150 Sn kV (n = 37) were included. Patients' age, sex, and serum uric acid levels were matched between the two groups. The types and incidence of image artefacts and radiation dose were evaluated. RESULTS: The 80/150 Sn kV group had significantly fewer patients with artefacts, compared to the 80/140 kV group [11 (30 %) of 37 vs 35 (94.6 %) of 37, p < 0.001]. Except for the motion artefact, the rest of the artefacts-skin, nail bed, submillimetre, motion, vascular, beam-hardening, clumpy artefact along tendon-were significantly less observed in the 80/150 Sn kV acquisitions. The dose-length product (DLP) and effective dose were significantly lower for the 80/150 Sn kV acquisitions compared with the 8s0/140 kV scans (DLP: 104.46 ± 10.66 mGy·cm vs 344.70 ± 56.39 mGy·cm, p < 0.001; effective dose: 1.04 ± 0.11 mSv vs 3.45 ± 0.56 mSv, p < 0.001). CONCLUSIONS: The 80/150 Sn kV voltage combination in dual-source DECT system could be used as one of the artefact reduction methods while reducing radiation dose for gout protocol when compared to the conventional 80/140 kV. KEY POINTS: • DECT has emerged as the leading modality for non-invasive diagnosis of gout. • Various X-ray tube voltage combinations are now feasible in dual-source DECT. • The 80/150 Sn kV acquisition could facilitate artefact reduction in gout protocol.
OBJECTIVES: In dual-source CT, dual-energy (DE) performance is affected by various X-ray tube voltage combinations with and without tin filter (Sn). The purpose of this study was to assess the utility of the 80/150 Sn kV voltage combination in terms of image artefact and radiation dose for DECT gout protocol, compared with the conventional 80/140 kV. METHODS: Seventy-four patients with suspected gout who underwent dual-source DECT examinations scanned at 80/140 kV (n = 37) and at 80/150 Sn kV (n = 37) were included. Patients' age, sex, and serum uric acid levels were matched between the two groups. The types and incidence of image artefacts and radiation dose were evaluated. RESULTS: The 80/150 Sn kV group had significantly fewer patients with artefacts, compared to the 80/140 kV group [11 (30 %) of 37 vs 35 (94.6 %) of 37, p < 0.001]. Except for the motion artefact, the rest of the artefacts-skin, nail bed, submillimetre, motion, vascular, beam-hardening, clumpy artefact along tendon-were significantly less observed in the 80/150 Sn kV acquisitions. The dose-length product (DLP) and effective dose were significantly lower for the 80/150 Sn kV acquisitions compared with the 8s0/140 kV scans (DLP: 104.46 ± 10.66 mGy·cm vs 344.70 ± 56.39 mGy·cm, p < 0.001; effective dose: 1.04 ± 0.11 mSv vs 3.45 ± 0.56 mSv, p < 0.001). CONCLUSIONS: The 80/150 Sn kV voltage combination in dual-source DECT system could be used as one of the artefact reduction methods while reducing radiation dose for gout protocol when compared to the conventional 80/140 kV. KEY POINTS: • DECT has emerged as the leading modality for non-invasive diagnosis of gout. • Various X-ray tube voltage combinations are now feasible in dual-source DECT. • The 80/150 Sn kV acquisition could facilitate artefact reduction in gout protocol.
Authors: Thomas G Flohr; Cynthia H McCollough; Herbert Bruder; Martin Petersilka; Klaus Gruber; Christoph Süss; Michael Grasruck; Karl Stierstorfer; Bernhard Krauss; Rainer Raupach; Andrew N Primak; Axel Küttner; Stefan Achenbach; Christoph Becker; Andreas Kopp; Bernd M Ohnesorge Journal: Eur Radiol Date: 2005-12-10 Impact factor: 5.315
Authors: Savvakis Nicolaou; Teresa Liang; Darra T Murphy; Jeff R Korzan; Hugue Ouellette; Peter Munk Journal: AJR Am J Roentgenol Date: 2012-11 Impact factor: 3.959
Authors: Andrew N Primak; Juan Carlos Ramirez Giraldo; Christian D Eusemann; Bernhard Schmidt; Birgit Kantor; Joel G Fletcher; Cynthia H McCollough Journal: AJR Am J Roentgenol Date: 2010-11 Impact factor: 3.959
Authors: Carlos Pineda; Luis M Amezcua-Guerra; Carla Solano; Pedro Rodriguez-Henríquez; Cristina Hernández-Díaz; Angelica Vargas; Fritz Hofmann; Marwin Gutiérrez Journal: Arthritis Res Ther Date: 2011-01-17 Impact factor: 5.156
Authors: Baptiste Dubief; Julien Avril; Tristan Pascart; Marie Schmitt; Romaric Loffroy; Jean-Francis Maillefert; Paul Ornetti; André Ramon Journal: Quant Imaging Med Surg Date: 2022-01
Authors: Anushri Parakh; Simon Lennartz; Chansik An; Prabhakar Rajiah; Benjamin M Yeh; Frank J Simeone; Dushyant V Sahani; Avinash R Kambadakone Journal: Radiographics Date: 2021 Jan-Feb Impact factor: 5.333
Authors: Su Min Lee; Hye Jung Choo; Sun Joo Lee; Sung Kwan Kim; In Sook Lee; Dong Wook Kim; Jin Wook Baek; Young Jin Heo Journal: Korean J Radiol Date: 2019-03 Impact factor: 3.500
Authors: Elin Svensson; Ylva Aurell; Lennart T H Jacobsson; Anton Landgren; Valgerdur Sigurdardottir; Mats Dehlin Journal: BMC Rheumatol Date: 2020-01-17
Authors: Maria Sotniczuk; Anna Nowakowska-Płaza; Jakub Wroński; Małgorzata Wisłowska; Iwona Sudoł-Szopińska Journal: J Clin Med Date: 2022-09-05 Impact factor: 4.964